Sidley represented Porch Group in the offering. Porch Group, Inc. announced a private placement of $333 million aggregate principal amount of 6.75% Convertible Senior Secured Notes...
You must be a Standard 1 Year member to access this content.
Gordon Dyal & Co., LLC. is acting as exclusive financial advisor and Davis Polk & Wardwell LLP and Allens are acting as legal counsel to Livent....
You must be a Standard 1 Year member to access this content.
Sidley advised Regal Rexnord on the deal, while Cravath represented Altra. Simpson Thacher represented JPMorgan Chase Bank, N.A. in providing committed financing for the acquisition. Regal...
You must be a Standard 1 Year member to access this content.
Sidley advised ZMC on the deal. Media, entertainment, communications and technology private equity firm ZMC announced its acquisition of Resonate, a provider of A.I. powered consumer data...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Wheels on the deal. Sidley Austin represented Athene Holding Ltd. and Donlen. Wheels, Inc. announced the combination with Donlen, LLC, in which Athene Holding...
You must be a Standard 1 Year member to access this content.
Sidley Austin advised Symplr on the deal. Symplr announced the acquisition of Halo Health, a provider of clinical communication and collaboration software. Symplr is a global leader...
You must be a Standard 1 Year member to access this content.
Debevoise & Plimpton advised Covéa Insurance on the deal while Sidley Austin LLP advised Porch Group, Inc. Covéa Insurance plc closed its definitive agreement to sell...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised ettain group on the deal while Sidley Austin represented ManpowerGroup Inc. ManpowerGroup (NYSE: MAN), the leading global workforce solutions company, excuted the...
You must be a Standard 1 Year member to access this content.
Sidley Austin advised the underwriters on the deal, while Choate and Latham & Watkins assisted Immuneering Corporation. Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP advised Tempest Therapeutics, Inc. on the deal. Tempest Therapeutics, Inc., a privately-held, clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP advised Tempest Therapeutics, Inc. on the deal. Tempest Therapeutics, Inc., a privately-held, clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted...
You must be a Standard 1 Year member to access this content.
